These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35349750)

  • 1. Lung donation and SARS-CoV-2 transmission: Missed detection versus missed opportunity?
    Van Slambrouck J; Van Raemdonck D; Wauters J; Vos R; Mombaerts P; Ceulemans LJ
    Immun Inflamm Dis; 2022 Apr; 10(4):e603. PubMed ID: 35349750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid.
    Van Slambrouck J; Schoenaers C; Laenen L; Jin X; Beuselinck K; Verdonck A; Wauters J; Molenberghs G; Vanaudenaerde BM; Vos R; Mombaerts P; Lagrou K; Ceulemans LJ
    J Virol Methods; 2024 Jan; 323():114848. PubMed ID: 37944670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
    LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Rapid Antigen Testing for SARS-CoV-2 in Remote Communities - Yukon-Kuskokwim Delta Region, Alaska, September 15, 2020-March 1, 2021.
    Hodges E; Lefferts B; Bates E; Desnoyers C; Bruden D; Bruce M; McLaughlin J
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(33):1120-1123. PubMed ID: 34411078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany.
    Wolf F; Matthes A; Markwart R; Bleidorn J
    Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():43-49. PubMed ID: 36372644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test.
    Young S; Taylor SN; Cammarata CL; Varnado KG; Roger-Dalbert C; Montano A; Griego-Fullbright C; Burgard C; Fernandez C; Eckert K; Andrews JC; Ren H; Allen J; Ackerman R; Cooper CK
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33023911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees.
    Cybulski DJ; Matthews Z; Kieffer JW; Casey TM; Osuna AB; Kasper K; Frankel DN; Aden J; Yun HC; Marcus JE
    Clin Infect Dis; 2024 Jan; 78(1):65-69. PubMed ID: 37610361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals.
    Bohn MK; Lippi G; Horvath AR; Erasmus R; Grimmler M; Gramegna M; Mancini N; Mueller R; Rawlinson WD; Menezes ME; Patru MM; Rota F; Sethi S; Singh K; Yuen KY; Wang CB; Adeli K;
    Clin Chem Lab Med; 2021 Aug; 59(9):1507-1515. PubMed ID: 33908222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the new 2.0 version of the Roche SARS-CoV-2 Rapid Antigen Test.
    Flinck H; Aittoniemi J
    J Virol Methods; 2023 Sep; 319():114758. PubMed ID: 37263352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor to recipient transmission of SARS-CoV-2 by lung transplantation despite negative donor upper respiratory tract testing.
    Kaul DR; Valesano AL; Petrie JG; Sagana R; Lyu D; Lin J; Stoneman E; Smith LM; Lephart P; Lauring AS
    Am J Transplant; 2021 Aug; 21(8):2885-2889. PubMed ID: 33565705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life.
    Roger S; Lefeuvre C; Pivert A; Ducancelle A; Savary D; Bouthry É; Le Guillou-Guillemette H
    J Med Virol; 2022 Apr; 94(4):1723-1727. PubMed ID: 34873718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The impact of the COVID‒19 pandemic on organ donation and transplantation in Hungary in 2020].
    Mihály S; Egyed-Varga A; Trnka-Szántay K; Deme O; Holtzinger E; Nacsa J; Piros L
    Orv Hetil; 2021 Jun; 162(23):890-896. PubMed ID: 34091437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral load may impact the diagnostic performance of nasal swabs in nucleic acid amplification test and quantitative antigen test for SARS-CoV-2 detection.
    Fujiya Y; Sato Y; Katayama Y; Nirasawa S; Moriai M; Saeki M; Yakuwa Y; Kitayama I; Asanuma K; Kuronuma K; Takahashi S
    J Infect Chemother; 2022 Nov; 28(11):1590-1593. PubMed ID: 35953013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Importance of Incorporating At-Home Testing Into SARS-CoV-2 Point Prevalence Estimates: Findings From a US National Cohort, February 2022.
    Qasmieh SA; Robertson MM; Rane MS; Shen Y; Zimba R; Picchio CA; Parcesepe AM; Chang M; Kulkarni SG; Grov C; Nash D
    JMIR Public Health Surveill; 2022 Dec; 8(12):e38196. PubMed ID: 36240020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.
    Lanari M; Biserni GB; Pavoni M; Borgatti EC; Leone M; Corsini I; Lazzarotto T
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test.
    Chan MMH; Leung KY; Zhang RRQ; Liu D; Fan Y; Khong MKW; Tam AR; Chen H; Yuen KY; Hung IFN; Chan KH
    Microbiol Spectr; 2022 Apr; 10(2):e0099321. PubMed ID: 35254121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.